Expressing support for the designation of April as "Co-Occurring Disorders Awareness Month".
Impact
The resolution highlights the importance of integrated treatment approaches that encompass both mental health and substance use disorders. By promoting awareness in April, the resolution aims to encourage earlier detection of such disorders, thereby improving the quality of care and health outcomes for affected individuals. This support aligns with ongoing efforts to enhance the effectiveness of treatment and management of individuals with these complex conditions.
Summary
House Resolution 1165 expresses support for the designation of April as 'Co-Occurring Disorders Awareness Month'. This initiative aims to raise awareness about the condition, which encapsulates the dual diagnosis of mental health disorders and substance use disorders. According to statistics from the Substance Abuse and Mental Health Services Administration, millions of adults in the United States are affected by co-occurring disorders, emphasizing the need for increased recognition and understanding of this issue.
Contention
While resolutions like HR1165 are generally supported across the political spectrum, the debate often centers around the allocation of resources for mental health and substance abuse programs. Opponents might argue about the effectiveness of public awareness campaigns versus funding for direct services, including treatment and rehabilitation options. The resolution seeks to foster dialogue around integrating services and understanding the interplay between mental health and substance use, which are often intertwined.
Recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of the month of September 2024 as "PCOS Awareness Month".